What is the Purdue Pharma bankruptcy settlement?

The Purdue Pharma bankruptcy settlement is a $7 billion deal approved by a federal bankruptcy judge, requiring the Sackler family to forfeit ownership of the Connecticut-based firm and contribute up to $7 billion to address thousands of lawsuits over the opioid crisis.

How much will the Sackler family have to pay in the Purdue Pharma settlement?

The Sackler family, who own Purdue Pharma, will have to contribute up to $7 billion as part of the bankruptcy settlement.

What is the impact of the Purdue Pharma bankruptcy deal on the opioid crisis?

The Purdue Pharma bankruptcy settlement is one of the largest opioid-related agreements, aiming to hold the company accountable for its role in the epidemic that has claimed over 900,000 lives in the U.S. since 1999.

Home / Health / Sackler Family to Forfeit Billions, Relinquish Purdue Pharma in Landmark Opioid Settlement

Sackler Family to Forfeit Billions, Relinquish Purdue Pharma in Landmark Opioid Settlement

15 Nov, 2025

•

Summary

Federal bankruptcy judge approves Purdue Pharma's $7 billion settlement
Sackler family required to give up ownership of the Connecticut-based firm
Deal aims to address thousands of lawsuits over the opioid epidemic

Sackler Family to Forfeit Billions, Relinquish Purdue Pharma in Landmark Opioid Settlement

On November 15, 2025, a federal bankruptcy court judge announced that he would approve OxyContin-maker Purdue Pharma's latest deal to settle thousands of lawsuits over the devastating toll of the opioid crisis. The agreement, overseen by U.S. Bankruptcy Judge Sean Lane, would require some members of the multibillionaire Sackler family who own the company to contribute up to $7 billion and relinquish their ownership of the Connecticut-based firm.

This new deal replaces a previous settlement that the U.S. Supreme Court had rejected last year, finding that it would have improperly protected the Sackler family from future lawsuits. The judge stated that he would explain his decision to approve the latest plan in a hearing scheduled for November 17, 2025.